Fischer Chemic reports standalone net loss of Rs 0.07 crore in the September 2021 quarter

Fischer Chemic reports standalone net loss of Rs 0.05 crore in the June 2021 quarter

Fischer Chemic reports standalone net loss of Rs 0.02 crore in the March 2021 quarter

The creamy layer - amongst the top performing stocks

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Fischer Medical Ventures Limited is primarily involved in trading laboratory chemicals and machinery. The company focuses on providing essential supplies for laboratory operations.

Fischer Medical Ventures Ltd

Fischer Medical Ventures Ltd

Scorecard

News & Opinions

Fischer Chemic reports standalone net loss of Rs 0.07 crore in the September 2021 quarter

Fischer Chemic reports standalone net loss of Rs 0.05 crore in the June 2021 quarter

Fischer Chemic reports standalone net loss of Rs 0.02 crore in the March 2021 quarter